Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shangying Hu

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|May 21, 2026
Memory Cell and Antibody Responses Following a Single Versus Two Doses of Escherichia coli-Produced Vaccine Against Human Papillomavirus Types 16 and 18: A Real-World Study in Chinese GirlsTianmeng Wen, Li Dong, Jiayi Li, et al.
BMC Medicine|March 3, 2021
Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling studyChangfa Xia, Xiaoqian Xu, Xuelian Zhao, et al.
International Journal of Cancer|June 1, 2017
Risk stratification and long-term risk prediction of E6 oncoprotein in a prospective screening cohort in ChinaQian Zhang, Li Dong, Shangying Hu, et al.
BMC Infectious Diseases|June 22, 2012
Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese womenJia Ji, Hai-Kui Sun, Jennifer S Smith, et al.
Virology Journal|June 1, 2025
HPV genotyping agreement between paired cervical cytological sample and biopsy across lesion severity and vaccinationShimin Chen, Qiaoyun Du, Jian Yin, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 23, 2018
Accuracy of triage strategies for human papillomavirus DNA-positive women in low-resource settings: A cross-sectional study in ChinaMargaret Wang, Shangying Hu, Shuang Zhao, et al.
Preventive Medicine|March 1, 2021
A nationwide post-marketing survey of knowledge, attitudes and recommendations towards human papillomavirus vaccines among healthcare providers in ChinaXiaoqian Xu, Yueyun Wang, Yawen Liu, et al.
Vaccine|November 27, 2020
A nationwide post-marketing survey of knowledge, attitude and practice toward human papillomavirus vaccine in general population: Implications for vaccine roll-out in mainland ChinaShangying Hu, Xiaoqian Xu, Yanyang Zhang, et al.
Infectious Agents and Cancer|September 12, 2024
Ranking the attribution of high-risk genotypes among women with cervical precancers and cancers: a cross-sectional study in Ningbo, ChinaShimin Chen, Shangying Hu, Jian Yin, et al.
International Journal of Cancer|December 30, 2009
Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collectionJerome L Belinson, Shangying Hu, Mayineur Niyazi, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|May 21, 2026
Memory Cell and Antibody Responses Following a Single Versus Two Doses of Escherichia coli-Produced Vaccine Against Human Papillomavirus Types 16 and 18: A Real-World Study in Chinese GirlsTianmeng Wen, Li Dong, Jiayi Li, et al.
BMC Medicine|March 3, 2021
Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling studyChangfa Xia, Xiaoqian Xu, Xuelian Zhao, et al.
International Journal of Cancer|June 1, 2017
Risk stratification and long-term risk prediction of E6 oncoprotein in a prospective screening cohort in ChinaQian Zhang, Li Dong, Shangying Hu, et al.
BMC Infectious Diseases|June 22, 2012
Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese womenJia Ji, Hai-Kui Sun, Jennifer S Smith, et al.
Virology Journal|June 1, 2025
HPV genotyping agreement between paired cervical cytological sample and biopsy across lesion severity and vaccinationShimin Chen, Qiaoyun Du, Jian Yin, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 23, 2018
Accuracy of triage strategies for human papillomavirus DNA-positive women in low-resource settings: A cross-sectional study in ChinaMargaret Wang, Shangying Hu, Shuang Zhao, et al.
Preventive Medicine|March 1, 2021
A nationwide post-marketing survey of knowledge, attitudes and recommendations towards human papillomavirus vaccines among healthcare providers in ChinaXiaoqian Xu, Yueyun Wang, Yawen Liu, et al.
Vaccine|November 27, 2020
A nationwide post-marketing survey of knowledge, attitude and practice toward human papillomavirus vaccine in general population: Implications for vaccine roll-out in mainland ChinaShangying Hu, Xiaoqian Xu, Yanyang Zhang, et al.
Infectious Agents and Cancer|September 12, 2024
Ranking the attribution of high-risk genotypes among women with cervical precancers and cancers: a cross-sectional study in Ningbo, ChinaShimin Chen, Shangying Hu, Jian Yin, et al.
International Journal of Cancer|December 30, 2009
Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collectionJerome L Belinson, Shangying Hu, Mayineur Niyazi, et al.
Pageof 7